Proteolysis Targeting Chimeras (PROTACs) based on celastrol induce multiple protein degradation for triple-negative breast cancer treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Proteolysis Targeting Chimeras (PROTACs) based on celastrol induce multiple protein degradation for triple-negative breast cancer treatment

Published:2024-01 Issue: Volume:192 Page:106624
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Gan Xuelan,Wang Fan,Luo Jianguo,Zhao Yunfei,Wang Yan,Yu Chao,Chen Jun^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference62 articles.

1. Interplay between MAPK/ERK signaling pathway and MicroRNAs: a crucial mechanism regulating cancer cell metabolism and tumor progression;Asl;Life Sci.,2021

2. Small molecules, big impact: 20 years of targeted therapy in oncology;Bedard;Lancet,2020

3. An overview of drug discovery and development;Berdigaliyev;Future Med. Chem.,2020

4. Treatment landscape of triple-negative breast cancer - expanded options, evolving needs;Bianchini;Nat. Rev. Clin. Oncol.,2022

5. Expanding the medicinal chemistry synthetic toolbox;Bostrom;Nat. Rev. Drug Discov.,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PROTAC technology: From drug development to probe technology for target deconvolution;European Journal of Medicinal Chemistry;2024-10

2. Proteolysis-targeting drug delivery system (ProDDS): integrating targeted protein degradation concepts into formulation design;Chemical Society Reviews;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP